This study is for patients who have a type of blood cancer that expresses the protein CD70, which includes acute myeloid leukemia (AML), T-cell leukemia or B-c…

Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T-Cell

~Estimated

~$10 – $6,250

Baylor College of MedicineNCT06345027

Phase 1

(H-49235) Trivalent Autologous T-Lymphocytes Co-Expressing Three Chimeric Antigen Receptors Targeting CD19, CD20 AND CD22 in Acute B-lineage Leukemia (TRICAR-ALL)

This is a gene transfer study for patients with a type of blood cancer called Acute Lymphoblastic Leukemia (ALL) that has come back or has not gone away after …

Leukemia, B-Cell

~Estimated

~$10 – $6,250

Baylor College of MedicineNCT05010564

Phase 3

A Phase 3 Open-Label, Randomized Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN-CLL-314)

The purpose of Part 1 of this study is to compare the efficacy and safety of pirtobruitinib (LOXO-305) to ibrutinib in participants with CLL/SLL; participants …

Chronic Lymphocytic LeukemiaLeukemia, LymphocyticLeukemia, B-cell+1 more

~Estimated

~$10 – $8,750

Loxo Oncology, Inc.NCT05254743